Results 11 to 20 of about 335,951 (265)

A giant prostatic hyperplasia treated by open surgery

International Journal of General Medicine, 2012
Soichiro Ogawa,1 Masahiko Manome,2 Michihiro Yabe,2 Yoshinobu Kuma,2 Masaaki Yamaoka,1 Yuichi Sato,1 Hidenori Akaihata,1 Toshiki Oguro,1 Masao Kataoka,1 Shin Kumagai,1 Yoshiyuki Kojima11Department of Urology, Fukushima Medical University, Fukushima ...
Ogawa S, Manome M, Yabe M, Kuma Y, Yamaoka M, Sato Y, Akaihata H, Oguro T, Kataoka M, Kumagai S, Kojima Y   +10 more
doaj   +1 more source

Analysis of Notch1 and Notch3 Signaling Pathway Components in Benign Prostatic Hyperplasia and Prostate Cancer Patients. [PDF]

J Clin Lab Anal
This study evaluates the association between Notch1 and Notch3 genetic variations and serum protein levels in patients with benign prostatic hyperplasia and prostate cancer. While genetic variations showed no significant link to disease risk, serum protein levels were significantly lower in prostate cancer and metastatic groups compared to healthy ...
Yagci E, Ozbayer C, Ozen A, Zengin G, Kurt H.   +4 more
europepmc   +2 more sources

Benign prostatic hyperplasia [PDF]

Revista da Associação Médica Brasileira, 2018
The minimally invasive procedures (mips) for the treatment of symptoms of benign prostatic hyperplasia (bph) are presented as attractive techniques due to their ease of accomplishment and the possibility of outpatient treatment. This guideline aims to present recommendations that may assist in decision making in patients with benign prostatic ...
Ricardo L. V. Nunes, Alberto A. Antunes, Antonio Silvinato, Wanderley M. Bernardo   +3 more
openaire   +4 more sources

Interstitial laser therapy of benign prostatic hyperplasia [PDF]

, 1999
The objective of interstitial laser coagulation (ILC) of benign prostatic enlargement is to achieve a marked volume reduction and to decrease bladder outlet obstruction and lower urinary tract symptoms with minimal morbidity.
Muschter, Rolf, Whitfield, Hugh
core   +1 more source

Randomised controlled trial of an interactive multimedia decision aid on benign prostatic hypertrophy in primary care [PDF]

, 2001
Objective To determine whether a decision aid on benign prostatic hypertrophy influences decision making, health outcomes, and resource use.Design Randomised controlled trial.Setting 33 general practices in the United Kingdom.Participants 112 men with ...
Davis, H, Haines, A, Coulter, A, Gray, A, Murray, E, Tai, SS   +5 more
core   +1 more source

Effect of heat exposure on viability and contractility of cultured prostatic stromal cells [PDF]

, 2000
Objectives: Different thermotherapeutic modalities such as transurethral microwave therapy or transurethral needle ablation have been developed to provide effective alternatives to surgical management of benign prostate hyperplasia (BPH).
Corvin, Stefan, Maneschg, Christoph, Klocker, Helmut, Radmayr, Christian, Boesch, Simone, Bartsch, Georg   +5 more
core   +1 more source

Urinary cholesterol excretion in men with benign prostatic hyperplasia and carcinoma of the prostate [PDF]

, 1966
Urinary excretion of nonesterified (NEC) and total cholesterol (TC) has been investigated in 79 patients with prostatic adenoma (BPH) and 48 patients with carcinoma of the prostate.
P. GIORDANO, Odom, Lorrie F., Ruiz Jorge, Lissette, Williams, Fiona L. R., Llombart-Bosh, Antonio, Angelika, Pickel, McNeely, Lee K., McCarthy, Donna O., Roy, S., Meagher, David P., Jr., G. MAZZINI, Kumar, Lalit, Bhangui, G. R., Daniel, William E., Lloyd, Owen L., Tandon, P. N., Alegret Rodríguez, Milagros, Pickel, A., Kochupillai, V., Elsässer, Erich, Machado Puerto, Isidro, Karl, Hans Josef, E. TRAVERSI, Dua, Harsch, Stadler, Alexander, Cowpe, Jonathan G., Green, Michael, Jüngst, Dieter, Blake, Marilyn, Marx, Franz J., Poole, Marten A., Haase, Gerald M., Ogden, Graham R.; id_orcid, E. ASCARI, MONTECUCCO, CARLOMAURIZIO, A. RICCARDI, Moskowitz, M., Grill, J. P., G. IPPOLITI, Ingle, J. N., Stanley, R. J., Zimmerman, R. R., Kushner, H. D., Schild, S. E., Thompson, W. M., Schaid, D. J., Roche, P. C., Smart, C. R., Krammer, B., Buskirk, S. J., Holleb, A. I., McLelland, R., INVERNIZZI, ROSANGELA, Van Wijnen, Andre J., Su, J. Q., Lian, Jane B., Shapiro, Stephanie, Krook, J. E., Maihle, N. J., Olsen, K. D., M. DANOVA, M. GIRINO, Fragoyannis, S, Costanza, Mary E., Foote, R. L., Stein, Janet L., F. PASQUALI, Henson, D. E., Witzig, T. E., Kunselman, S. J., Wall, James, Hartmann, L. C., G. UCCI, Hutter, R. V., Kung'u, A., Wold, L. E., Farr, G. H., Sperry, Kris, Yalcin, S, Stein, Gary S., Pollack, Alan, Zagars, Gunar K, Kavadi, Vivek S   +82 more
core   +2 more sources

MEDICAL TREATMENT OF BENIGN PROSTATIC HYPERPLASIA AFTER CYSTOLITHOTRIPSY [PDF]

Zagazig University Medical Journal, 2018
Background: Benign  prostatic hyperplasia (BPH)  is a noncancerous increase of  the size of the prostate gland. The two main medication classes for BPH management are alpha blockers  and 5α -reductase inhibitors .Urinary bladder stones account for 5% of ...
Abraheem Ali, Mohammed Seleem, Ahmed Ali, Mohammed Mohammed   +3 more
doaj   +1 more source

Effect of aging on endogenous level of 5 alpha-dihydrotestosterone, testosterone, estradiol, and estrone in epithelium and stroma of normal and hyperplastic human prostate. [PDF]

, 1993
associated with aging. Thus, the question arises whether or not a correlation exists between the well known prostatic androgen and estrogen accumulation and aging.
Nass, Ralf, Tunn, Sabine, Krieg, Michael, M. Krieg   +3 more
core   +2 more sources

TRANSURETHRAL THULIUM:YAG LASER VAPOENUCLEATION IN BENIGN PROSTATIC HYPERPLASIA TREATMENT

Arta Medica, 2021
Objectives. The aim of the study was to analyze evidence based data from existing sources, regarding the role and the efficacy of transurethral Thulium:YAG laser vapoenucleation in benign prostatic hyperplasia treatment. Material and methods.
Alexei Pleșacov, Ivan Vladanov, Vitalii Ghicavîi   +2 more
doaj   +3 more sources